Indo US Bio-Tech Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Jun'26

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Jun 2026 is 26.79% vs 14.12% in Mar 2026

Standalone Net Profit

QoQ Growth in quarter ended Jun 2026 is 54.31% vs -34.33% in Mar 2026

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 23.29% vs -22.41% in Mar 2026

Interest

QoQ Growth in quarter ended Jun 2026 is 23.33% vs -22.08% in Mar 2026

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

Compare Quarterly Results Of Indo US Bio-Tech With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

32.99

7.43

25.56

344.01%

Other Operating Income

0.00

Total Operating income

32.99

7.43

25.56

344.01%

Raw Material Cost

0.00

4.92

-4.92

-100.00%

Purchase of Finished goods

5.24

0.00

5.24

(Increase) / Decrease In Stocks

12.16

-1.24

13.40

1,080.65%

Employee Cost

0.33

0.45

-0.12

-26.67%

Power Cost

0.00

Manufacturing Expenses

8.63

0.00

8.63

Selling and Distribution Expenses

0.00

Other Expenses

2.66

0.70

1.96

280.00%

Total Expenditure (Excl Depreciation)

29.02

4.83

24.19

500.83%

Operating Profit (PBDIT) excl Other Income

3.97

2.60

1.37

52.69%

Other Income

0.12

0.09

0.03

33.33%

Operating Profit (PBDIT)

4.09

2.69

1.40

52.04%

Interest

0.74

0.54

0.20

37.04%

Exceptional Items

0.00

Gross Profit (PBDT)

3.35

2.15

1.20

55.81%

Depreciation

0.27

0.14

0.13

92.86%

Profit Before Tax

3.08

2.01

1.07

53.23%

Tax

0.04

0.52

-0.48

-92.31%

Provisions and contingencies

0.00

Profit After Tax

3.04

1.49

1.55

104.03%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

3.04

1.49

1.55

104.03%

Equity Capital

20.05

5.32

14.73

276.88%

Face Value

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

1.52

2.80

-1.28

-45.71%

Diluted Earnings per share

1.51

2.04

-0.53

-25.98%

Operating Profit Margin (Excl OI)

12.03%

34.99%

0.00

-22.96%

Gross Profit Margin

10.15%

28.94%

0.00

-18.79%

PAT Margin

9.21%

20.05%

0.00

-10.84%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 32.99 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 26.79% vs 14.12% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 7.21% vs 24.47% in Jun 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 3.04 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 54.31% vs -34.33% in Mar 2026

YoY Growth in quarter ended Jun 2026 is -35.32% vs 48.26% in Jun 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 3.97 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 23.29% vs -22.41% in Mar 2026

YoY Growth in quarter ended Jun 2026 is -27.42% vs 48.24% in Jun 2025

Quarterly - Interest

Interest 0.74 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 23.33% vs -22.08% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 64.44% vs 36.36% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 12.03%

in Jun 2026

Figures in %

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025